Skip to main content

Table 1 Demographic and clinical characteristics of the study sample

From: Response inhibition alterations in migraine: evidence from event-related potentials and evoked oscillations

 

MwoA (n = 22)

(M ± SEM)

Controls (n = 25)

(M ± SEM)

Group comparison

Age, years

30.86 ± 1.21

30.24 ± 0.70

t (45) = − 0.46, p > 0.05

Gender (F/M)

(19/3)

(18/7)

χ2 = 2.40, p > 0.05

Education, years

15.55 ± 0.59

15.32 ± 0.45

t (45) = −0.31, p > 0.05

BMI [kg/m2]

21.09 ± 0.77

21.04 ± 0.52

t (45) = − 0.06, p > 0.05

SAS

44.43 ± 2.27

39.45 ± 1.49

t (45) = − 1.88, p > 0.05

SDS

44.67 ± 2.97

42.85 ± 2.13

t (45) = − 0.51, p > 0.05

Duration of migraine, hours

30.61 ± 5.47

  

History of migraine, years

12.41 ± 1.34

Migraine frequency, times per month

5.00 ± 0.92

Severity of headache (VAS scale)

8.23 ± 0.25

  1. VAS visual analog scale, with 0 indicating no pain and 10 worst possible pain, SAS Self-Rating Anxiety Scale, SDS Self-Rating Depression Scale, BMI body mass index, M mean, SEM standard error of the mean